PHARMA IMPULSES

MEETS ACHEMA

LIVE Stream

Program Pharma Impulses 2024

Harro Höfliger Verpackungsmaschinen GmbH

June 10, 2024 | 10.30 - 11.00 am

Transformation towards the factory of the future

Discover the future of pharmaceutical manufacturing in this presentation with Harro Höfliger. What are the reasons to move towards Stericlean+, the new benchmark for aseptic robotic applications? How is the access line redefining standards for medical device assembly?

Learn about the shift from automation to autonomy, the growing need for autonomous processes due to a scarcity of skilled workers, and the rising costs of personnel. Additionally, quality related risks need to be addressed with state-of-the-art technology.

Witness how the synergy between logistics devices from Stäubli and machine processes from Harro Höfliger addresses the emerging demands in intralogistics.

Join Pharma Impulses X ACHEMA to see that reducing operators in the manufacturing area is not just a possibility – the future starts now!

SPEAKER

Christian Kollecker | Sales Director Aseptic Technologies

Stefan Sommer | Sales Director Device Assembly Technologies

Azbil Telstar, Spain

June 11, 2024 | 10.30 - 11.00 am

How to automate legacy freeze dryers to fulfill Annex I GMP

Azbil Telstar, Stäubli Robotics and Zimmer Group have worked closely together to devise a solution aimed at automating the loading and unloading process of legacy freeze dryers for both vials and bulk materials. This Proof of Concept (PoC) entails the elimination of operator intervention within the cleanroom environment. This is achieved through the implementation of an Autonomous Mobile Robot (AMR) equipped with a 6-axis robot and a loading/unloading (L/U) cart positioned in proximity to the freeze dryer.

This update can be swiftly implemented while ensuring the continuous productivity of the production line. An upgrade of this PoC is in progress in order to run in Grade A addressing the Annex 1 requirement.

SPEAKER

Jordi Serrat | Technology and Operations Manager

SKAN AG, Switzerland

June 11, 2024 | 11.00 - 11.30 am

How to test and validate a robot for Pharma

Stäubli and SKAN, the worldwide leading manufacturer of isolator systems for aseptic drug manufacturing, will discuss about the requirements for robots in pharma industry and aseptic environments specifically.

Stäubli and SKAN‘s collaboration has driven the development of new features for the Stericlean package to ensure that the Stericlean+ robots are suitable for integration into pharmaceutical isolators and operation under aseptic manufacturing conditions.

Primary factors that were evaluated, include

Design and materials of the entire outer surface of the robots which need to be cleaned and decontaminated regularly and efficiently
Risk of particle generation by moving parts and how special attention was needed to go into the design and sealing of joints

At Pharma Impulses X ACHEMA Maximilian Mittelviefhaus, Head Research & SKANalytix, SKAN, details the procedure behind this comprehensive testing.

SPEAKER

Maximilian Mittelviefhaus | Research Manager

Novo Nordisk, Denmark

June 12, 2024 | 10.30 - 11.00 am

For a safer, more productive & reliable pharma industry – Mobile Robotics

In this presentation you will find out why and how Mobile Robotics could be a game changer on the Pharma factory floor.

Through concrete use cases, you will have a sneak view into the potential mobile robotic applications in Pharma production environment.

Learn more about Novo Nordisk & Stäubli cooperation and commitment to developing a cleanroom mobile robot for the Pharma industry including the process and mindset to do so.

SPEAKER

Hashim Dad Malik | Senior Project Manager

Milad Jami | Head of Robotics - Manufacturing Development

Cellular Origins Ltd, UK

June 12, 2024 | 11.00 - 11.30 am

Enabling patient access to cell therapies for today and tomorrow

Stäubli and Cellular Origins will discuss about how to bring advanced industrial automation to bioprocess.

What problem is Cellular Origins solving?

Cell therapies cannot be manufactured at scale. The costs are too high and there is insufficient manufacturing capacity, all driven by the process being too labour intensive.

Therapy developers use the best tools for the biology, even if these are highly manual.
Moving away from these for commercialization is too risky due to regulatory resubmission requirements and biological uncertainty.
Therapy developers are also worried that if they adopt the wrong automation platform now it will made absolete when new technologies emerge.

Join the Pharma Impulses X ACHEMA session to learn more how Cellular Origins enables scalable, cost effective, space efficient cell therapy manufacture to transform patient access to cell therapies.

SPEAKER

Dan Strange | CTO

Leo Steenson | Robotic Engineer

We are here for you. All over the world.

Search Stäubli website

Stäubli in Hong Kong

PHARMA IMPULSES

LIVE Stream

Program Pharma Impulses 2024

Harro Höfliger Verpackungsmaschinen GmbH

SPEAKER

Azbil Telstar, Spain

SPEAKER

SKAN AG, Switzerland

SPEAKER

Novo Nordisk, Denmark

SPEAKER

Cellular Origins Ltd, UK

SPEAKER

Fast moving technology

Copyright @ 2024 Stäubli International AG. All rights reserved.

Stäubli in Hong Kong